Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
1.
Transplant Proc ; 50(8): 2545-2547, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-30316395

RESUMEN

PURPOSE: Renal transplant patients with vascular rejection type acute T cell-mediated rejection (ATCMR) grade II have a poor prognosis. Vascular lesions in those cases are thought to randomly occur, thus we searched for a novel pathological marker related to vascular rejection in kidney transplantation. METHODS: We determined pathological characteristics in 14 ATCMR grade II patients treated during an acute phase from 2004 to 2013. We then examined whether those findings appeared in transplant kidney biopsy specimens, except for cases of vascular rejection, in patients examined from 2010 to 2014. RESULTS: In 9 of the 14 ATCMR grade II patients, phlebitis was accompanied by inflammatory cells that formed polypoid projections in the venous lumen and partial disappearance of vascular endothelium. Further investigation showed those inflammatory cells to be T cells and macrophages. Histological findings revealed coexisting phlebitis in 2 of 13 patients with ATCMR grade I, 3 of 24 with borderline changes, and none with normal findings. Phlebitis occurred at a significantly greater rate than the other findings in cases of vascular rejection (P < .05). However, there was no significant difference in regard to graft survival between patients with and without phlebitis (P = .1829). CONCLUSION: Our results suggest severe phlebitis as a novel finding associated with the pathology of vascular rejection in patients with a renal allograft.


Asunto(s)
Rechazo de Injerto/inmunología , Rechazo de Injerto/patología , Trasplante de Riñón/efectos adversos , Flebitis/complicaciones , Adulto , Femenino , Supervivencia de Injerto/inmunología , Humanos , Masculino , Persona de Mediana Edad , Flebitis/patología , Linfocitos T/inmunología , Trasplante Homólogo
2.
Transplant Proc ; 48(3): 781-5, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-27234735

RESUMEN

BACKGROUND: Utilization of everolimus (EVR) has been increasing in recent years for patients undergoing renal transplantation to reduce calcineurin inhibitor (CNI) levels. However, an optimum regimen has yet to be established. METHODS: We retrospectively examined 12 renal transplant recipients who underwent an induction immunosuppressive protocol; the protocol comprises 5 agents, including EVR plus low-dose tacrolimus extended-release (TAC-ER) treatment. We compared those findings from those of 14 patients who underwent a conventional protocol without EVR. Clinical outcome and pathologic changes were assessed by using protocol graft biopsy findings obtained at 3 months and 1 year after transplantation. RESULTS: The estimated glomerular filtration rate was significantly higher for the EVR group at both 3 months and 1 year compared with the conventional group (P < .01 and P = .03, respectively). TAC-ER trough levels were also significantly lower at 3 months and 1 year (both, P < .01). Histologic findings of the 3-month protocol biopsy samples in the EVR group revealed 4 cases of borderline change and 2 of acute cellular-mediated rejection. The findings from the 1-year biopsy samples revealed 10 cases with normal findings with no evidence of CNI toxicity. Patients in the EVR group developed subclinical borderline change and acute cellular-mediated rejection after 3 months at a significantly higher rate than the conventional group (P = .02). CONCLUSIONS: Use of the present therapeutic strategy successfully maintained the trough of each drug at a lower level, and it also kept renal function stable up to 1 year after transplantation.


Asunto(s)
Everolimus/uso terapéutico , Supervivencia de Injerto , Inmunosupresores/uso terapéutico , Trasplante de Riñón , Tacrolimus/uso terapéutico , Adulto , Anciano , Preparaciones de Acción Retardada/uso terapéutico , Relación Dosis-Respuesta a Droga , Quimioterapia Combinada , Femenino , Estudios de Seguimiento , Tasa de Filtración Glomerular , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Adulto Joven
3.
Transplant Proc ; 48(3): 890-2, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-27234760

RESUMEN

OBJECTIVES: Current adherence to dietary recommendations for chronic kidney disease was evaluated in kidney transplant patients in the maintenance phase. METHODS: A total of 268 maintenance phase kidney transplant patients were included in the study. Estimated daily intakes of oral protein and salt were calculated from 24-h urinary excretion of nitrogen and sodium, respectively. Dietary recommendations for chronic kidney disease, as issued in 2014 by the Japanese Society of Nephrology, were used as the basis for assessing diet. RESULTS: The study included 114 female patients and 154 male patients. The mean age, posttransplantation years, body mass index, estimated glomerular filtration rate, and 24-h urinary excretion of protein were 56.3 years, 11.2 years, 22.0 kg/m(2), 42.6 mL/min/1.73 m(2), and 321 mg/d, respectively. Estimated daily protein and salt intakes were 0.98 ± 0.26 g/kg/d and 9.3 ± 3.9 g/d. Only 47 patients (17.5%) in the case of salt intake and 105 patients (39.2%) in the case of protein intake were within reference values. The 24-h urinary protein excretion of the daily salt intake-adherent group (<6 g) was significantly less than that of the nonadherent group (≥6 g) (P = .021). CONCLUSIONS: The adherence rate to dietary recommendations for chronic kidney disease in kidney transplant patients was low. The 24-h urinary protein excretion of the daily salt intake-adherent group was significantly less than that of the nonadherent group. Dietary therapy for these patients may have the potential to improve kidney graft function and survival.


Asunto(s)
Dieta/normas , Tasa de Filtración Glomerular/fisiología , Adhesión a Directriz , Trasplante de Riñón , Insuficiencia Renal Crónica/dietoterapia , Femenino , Humanos , Masculino , Persona de Mediana Edad , Insuficiencia Renal Crónica/fisiopatología , Insuficiencia Renal Crónica/orina , Sodio/orina
4.
Prostate Cancer Prostatic Dis ; 15(4): 386-90, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22777394

RESUMEN

BACKGROUND: Asymptomatic prostatic inflammation may cause increased PSA in some men, leading to unnecessary prostate biopsy. We investigated whether the differential white cell count could predict the result of prostate biopsy. METHODS: Prostate needle biopsy was carried out in 323 Japanese men with elevated PSA levels or abnormal digital rectal findings. White blood cell count (WBC), differential white cell count (neutrophils, lymphocytes, basophils, eosinophils, and monocytes), and serum C-reactive protein level were assessed for associations with biopsy findings. RESULTS: In all, 203 (62.1%) were positive for prostate cancer. WBC, neutrophil count, age, PSA, prostate volume, and PSA density (PSAD) were associated with the results of biopsy (P<0.05). Multivariate analysis showed that neutrophil count, age, PSA, prostate volume and PSAD were independent predictors. When the cut-off neutrophil count was set at 2900 µl(-1), 78 of 104 men (75.0%) with a count below this value had a positive biopsy, while 125 of 219 (57.0%) men with a count above this value were positive. The area under the receiver-operator characteristics curve (AUC) for the predicted probability of a positive biopsy for prostate cancer according to the optimum logistic model was 0.83 (95% confidence interval (CI) 0.78-0.87), while the AUC for PSA was 0.70 (95% CI 0.64-0.76) and that for PSAD was 0.79 (95% CI 0.74-0.84). CONCLUSIONS: An elevated neutrophil count may be a good indicator of a benign prostate biopsy. Men with a low neutrophil count and an increase of serum PSA should strongly be considered for biopsy.


Asunto(s)
Calicreínas/sangre , Neutrófilos/patología , Antígeno Prostático Específico/sangre , Próstata , Neoplasias de la Próstata , Biomarcadores de Tumor/sangre , Biopsia , Recuento de Células Sanguíneas , Proteína C-Reactiva/metabolismo , Humanos , Masculino , Próstata/metabolismo , Próstata/patología , Neoplasias de la Próstata/sangre , Neoplasias de la Próstata/diagnóstico , Neoplasias de la Próstata/patología
5.
Transplant Proc ; 41(1): 52-4, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19249473

RESUMEN

Ischemia/reperfusion (I/R) injury, which induces extensive loss of tubular epithelial cells, is associated with delayed graft function following kidney transplantation. Recent reports have suggested that cell death by I/R injury occurs by autophagy, a cellular degradation process responsible for the turnover of unnecessary or dysfunctional organelles and cytoplasmic proteins, as well as by apoptosis. Recently, we demonstrated that overexpression of the anti-apoptotic factor, Bcl-2, inhibited tubular apoptosis and subsequent tubulointerstitial damage after I/R injury. Autophagy is also observed in cells undergoing cell death in several diseases. Therefore, we hypothesized that increased Bcl-2 protein may protect tubular epithelial cells by suppressing autophagy and inhibiting apoptosis. In the present study, a transgenic mouse model (LC3-GFP TG) in which autophagosomes are labeled with LC3-GFP and Bcl-2/LC3-GFP double transgenic mice (Bcl-2/LC3-GFP TG) were used to examine the effect of Bcl-2 on I/R-induced autophagy. I/R injury, which is associated with marked disruption of normal tubular morphology, promoted the formation of LC3-GFP dots, representing extensively induced autophagosomes. On electron microscopy, the autophagosomes contained mitochondria in I/R-injured tubular epithelial cells. In contrast, Bcl-2 augmentation suppressed the formation of autophagosomes and there was less tubular damage. In conclusion, Bcl-2 augmentation protected renal tubular epithelial cells from I/R injury by suppressing autophagosomal degradation and inhibiting tubular apoptosis.


Asunto(s)
Daño por Reperfusión/prevención & control , Animales , Autofagia/efectos de los fármacos , Células Epiteliales/efectos de los fármacos , Células Epiteliales/patología , Células Epiteliales/fisiología , Genes Reporteros , Genes bcl-2 , Humanos , Ratones , Ratones Transgénicos , Proteínas Proto-Oncogénicas c-bcl-2/uso terapéutico , Piruvato Quinasa/genética , Ratas , Daño por Reperfusión/patología
6.
Oncogene ; 26(12): 1748-56, 2007 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-16964285

RESUMEN

Apoptosis-associated speck-like protein containing a CARD (ASC) is an adaptor molecule that mediates apoptotic and inflammatory signals, and implicated in tumor suppression. However, the mechanism of ASC-mediated apoptosis has not been well elucidated. Here, we investigated the molecular mechanisms of ASC-mediated apoptosis in several cell lines using a caspase recruitment domain 12-Nod2 chimeric protein that transduces the signal from muramyl dipeptide into ASC-mediated apoptosis. Experiments using dominant-negative mutants, small-interfering RNAs and peptide inhibitors for caspases indicated that caspase-8 was generally required for ASC-mediated apoptosis, whereas a requirement for caspase-9 depended on the cell type. In addition, caspase-like apoptosis-regulatory protein (CLARP)/Fas-like inhibitor protein, a natural caspase-8 inhibitor, suppressed ASC-mediated apoptosis, and Clarp-/- mouse embryonic fibroblasts were highly sensitive to ASC-mediated apoptosis. Bax-deficient HCT116 cells were resistant to ASC-mediated apoptosis as reported previously, although we failed to observe colocalization of ASC and Bax in cells. Like Fas-ligand-induced apoptosis, the ASC-mediated apoptosis was inhibited by Bcl-2 and/or Bcl-XL in type-II but not type-I cell lines. Bid was cleaved upon ASC activation, and suppression of endogenous Bid expression using small-interfering RNAs in type-II cells reduced the ASC-mediated apoptosis. These results indicate that ASC, like death receptors, mediates two types of apoptosis depending on the cell type, in a manner involving caspase-8.


Asunto(s)
Apoptosis/fisiología , Proteína Proapoptótica que Interacciona Mediante Dominios BH3/fisiología , Proteínas del Citoesqueleto/fisiología , Animales , Secuencia de Bases , Proteínas Adaptadoras de Señalización CARD , Células COS , Línea Celular , Chlorocebus aethiops , Humanos , ARN Interferente Pequeño
7.
Bone Marrow Transplant ; 36(12): 1071-5, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16247437

RESUMEN

Hepatic veno-occlusive disease (VOD) is a severe complication of hematopoietic stem cell transplantation (SCT). When monitored with hand-held color Doppler ultrasonography during day -7 to +35 around SCT, reversed blood flow in the segmental branches of the portal vein was detected in nine of 56 patients who had undergone SCT. Three of nine patients had clinical evidence of VOD, but six patients did not fulfill the criteria for diagnosis of VOD initially. Two patients progressed to clinical VOD at a later date and the reversed portal flow disappeared with or without treatment for VOD in the other four patients. Monitoring for reversed portal flow with color Doppler ultrasonography may be a useful tool for the early diagnosis of VOD, and may improve prognosis by allowing early initiation of treatment.


Asunto(s)
Trasplante de Células Madre Hematopoyéticas/efectos adversos , Trasplante de Células Madre Hematopoyéticas/métodos , Enfermedad Veno-Oclusiva Hepática/diagnóstico por imagen , Enfermedad Veno-Oclusiva Hepática/diagnóstico , Hipertensión Portal/diagnóstico , Vena Porta/diagnóstico por imagen , Ultrasonografía Doppler/métodos , Adolescente , Adulto , Anciano , Niño , Progresión de la Enfermedad , Femenino , Humanos , Hipertensión Portal/diagnóstico por imagen , Hepatopatías/diagnóstico , Hepatopatías/diagnóstico por imagen , Masculino , Persona de Mediana Edad , Factores de Tiempo , Resultado del Tratamiento , Ultrasonografía/métodos , Ácido Ursodesoxicólico/farmacología
8.
Clin Transplant ; 18 Suppl 11: 29-33, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15191370

RESUMEN

Angiotensin-converting enzyme inhibitor (ACEI) has become recognized as agents that have renoprotective effects in the treatment of progressive renal diseases including post-transplant kidneys. Previously we demonstrated the safety and effectiveness of ACEI treatment on the hypertensive proteinuric post-transplant patients (N = 10) who had been followed up for 12 months. However, not all patients show good response in urinary protein reduction. We aimed to analyse the histopathological factor(s) affecting the responsiveness of proteinuria to ACEI treatment. Fourteen post-transplant patients with proteinuria who were treated with ACEI and underwent allograft biopsy were analysed. Eight patients showed 50% or more reduction in proteinuria (responder). The other 6 patients showed less (< 50%) reduction in proteinuria (non-responder). There was no difference in clinical characteristics (BP, renal function, donor age, recipient body mass index), dietary sodium or protein intake, and diuretic use between the two groups. As a histopathological characteristic, glomerular size in responder group was significantly larger than that in non-responder group. This suggests that the large glomerular size at least partly contributes to the responsiveness in urinary protein reduction to ACEI treatment in kidney allograft recipients with proteinuria.


Asunto(s)
Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico , Glomérulos Renales/patología , Trasplante de Riñón/patología , Proteinuria/tratamiento farmacológico , Adulto , Anciano , Biopsia , Humanos , Hipertrofia , Persona de Mediana Edad , Proteinuria/fisiopatología , Trasplante Homólogo
9.
Bone Marrow Transplant ; 30(8): 527-9, 2002 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12379893

RESUMEN

A 51-year-old man with non-Hodgkin's lymphoma (NHL) was treated with high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation (PBSCT). Although he had HLA-DRB1 0405 and a positive rheumatoid factor, he was unlikely to develop rheumatoid arthritis (RA) according to diagnostic criteria. However, the patient developed RA 40 days after transplantation. Our experience suggests that the systemic autoimmune disease, RA, may occur in patients with predisposing factors after autologous PBSCT.


Asunto(s)
Artritis Reumatoide/etiología , Trasplante de Células Madre de Sangre Periférica/efectos adversos , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Artritis Reumatoide/diagnóstico , Autoinmunidad , Antígenos HLA-DR , Cadenas HLA-DRB1 , Humanos , Linfoma no Hodgkin/complicaciones , Linfoma no Hodgkin/terapia , Masculino , Persona de Mediana Edad , Factor Reumatoide , Factores de Riesgo , Trasplante Autólogo
10.
Eur J Immunol ; 31(8): 2504-11, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11500835

RESUMEN

The ectopic expression of Fas ligand (FasL/CD95L) in tissues or tumors induces neutrophil infiltration and the destruction of the tissues or the rejection of tumors. It has been suggested that the infiltrated neutrophils are responsible for the latter phenomena. FasL is synthesized as a type II transmembrane protein, and soluble FasL is produced by a proteolytic mechanism from the membrane-bound form. We previously demonstrated that uncleavable membrane-bound FasL of mice induces IL-1 beta release from inflammatory cells, and suggested that the IL-1 beta enhances neutrophil infiltration. However, recent papers reported that human soluble FasL is directly chemoattractive to neutrophils in vitro and proposed that the soluble form of FasL is responsible for its inflammatory activity. Therefore, in this report, we investigated which form is responsible for the inflammatory activities of human FasL. We produced tumor cell lines expressing one or both forms of human FasL. Cells expressing both forms or only the membrane-bound form of FasL induced neutrophil infiltration when transplanted into the peritoneal cavity of syngeneic mice, while cells expressing only the soluble form did not. Purified soluble FasL failed to induce neutrophil infiltration in vivo. IL-1 beta release from inflammatory peritoneal exudate and acceleration of tumor rejection were also mediated by membrane-bound but not soluble FasL. These results indicate that the membrane-bound form of FasL is primarily responsible for its inflammatory activity.


Asunto(s)
Membrana Celular/metabolismo , Inflamación/inmunología , Glicoproteínas de Membrana/inmunología , Glicoproteínas de Membrana/metabolismo , Animales , Proteína Ligando Fas , Femenino , Citometría de Flujo , Humanos , Inflamación/metabolismo , Inflamación/patología , Interleucina-1/metabolismo , Glicoproteínas de Membrana/química , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos , Trasplante de Neoplasias , Neoplasias Experimentales/inmunología , Infiltración Neutrófila , Peritoneo/inmunología , Peritoneo/metabolismo , Peritoneo/patología , Solubilidad , Células Tumorales Cultivadas
11.
Br J Haematol ; 115(4): 945-8, 2001 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11843831

RESUMEN

We report two cases in which visualization of the segmental branch of the hepatic portal vein with the colour Doppler ultrasonography (US) technique was useful for the early diagnosis of veno-occlusive disease. The change in blood flow in the segmental branch of the portal vein occurred 5 and 6 d before the clinical criteria were fulfilled in the two cases. Reverse flow in the segmental branch began partially in the liver at first, and then spread to the whole liver several days later. All the US findings in both cases disappeared after thrombolytic therapy.


Asunto(s)
Trasplante de Células Madre Hematopoyéticas , Venas Hepáticas/diagnóstico por imagen , Enfermedad Veno-Oclusiva Hepática/diagnóstico por imagen , Vena Porta/diagnóstico por imagen , Ultrasonografía Doppler en Color , Adulto , Alprostadil/uso terapéutico , Anticoagulantes/uso terapéutico , Heparina de Bajo-Peso-Molecular/uso terapéutico , Enfermedad Veno-Oclusiva Hepática/tratamiento farmacológico , Humanos , Masculino , Persona de Mediana Edad , Flujo Sanguíneo Regional , Trasplante Homólogo
12.
Hinyokika Kiyo ; 46(7): 495-8, 2000 Jul.
Artículo en Japonés | MEDLINE | ID: mdl-10965459

RESUMEN

A 67-year-old male was admitted with a three-month history of voiding difficulty. Prostate specific antigen remained within the normal limit. Under the diagnosis of benign prostatic hypertrophy, transurethral resection of prostate was performed. Pathological examination of the resected specimens of the prostate revealed transitional cell carcinoma. Two courses of systemic M-VAC (methotrexate, vinblastine, doxorubicin, cisplatin) chemotherapy were performed, followed by cystoprostatourethrectomy, pelvic lymphadenectomy, and ileal conduit construction. Now one year has elapsed, with no clinical signs of recurrence.


Asunto(s)
Carcinoma de Células Transicionales/terapia , Neoplasias de la Próstata/terapia , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Carcinoma de Células Transicionales/patología , Cisplatino/administración & dosificación , Terapia Combinada , Doxorrubicina/administración & dosificación , Humanos , Masculino , Metotrexato/administración & dosificación , Neoplasias de la Próstata/patología , Resultado del Tratamiento , Procedimientos Quirúrgicos Urológicos , Vinblastina/administración & dosificación
13.
Hinyokika Kiyo ; 46(5): 353-5, 2000 May.
Artículo en Japonés | MEDLINE | ID: mdl-10876763

RESUMEN

A 72-year-old male was admitted to our hospital with the complaint of right painless swelling of extratesticular scrotal content. Laboratory examinations were unremarkable. Under the diagnosis of an intrascrotal lipoma, the tumor was resected. The removed specimen weighed 115 g. Histopathological findings revealed lipoma. Other cases from the Japanese publications, together with our case, are reviewed.


Asunto(s)
Neoplasias de los Genitales Masculinos/cirugía , Lipoma/cirugía , Escroto , Anciano , Neoplasias de los Genitales Masculinos/diagnóstico , Neoplasias de los Genitales Masculinos/patología , Humanos , Lipoma/diagnóstico , Lipoma/patología , Masculino , Resultado del Tratamiento
14.
Biochem Biophys Res Commun ; 272(3): 765-76, 2000 Jun 16.
Artículo en Inglés | MEDLINE | ID: mdl-10860829

RESUMEN

Nuclear Factor of Activated T cell (NFAT) is a family of transcription factors that are important for the coordinate expression of various cytokines and immunoregulatory cell surface molecules in T cells and other types of cells in the immune system. In addition, analysis of gene disrupted mice revealed that some members of NFAT family are important for the development of myocardium, myocardial hypertrophy, and mesenchymal stem cells. NFAT family proteins have two conserved domains, the NFAT Homology Domain (NHD) and the Rel Similarity Domain (RSD). The RSD is DNA binding and AP-1 interacting domain which has structural similarity to the Rel Homology Region, the DNA binding domain of Rel family proteins. The NHD is a regulatory domain required for the Ca regulated translocation of NFAT. We report here the isolation and initial characterization of a novel RSD containing protein designated NFATz. NFATz has a RSD but no NHD. NFATz protein is localized in the nucleus without Ca signal. There is no detectable binding to a typical NFAT site even in the presence of AP-1, and it is not capable of activating transcription through the NFAT site. The chromosomal location determined by FISH revealed that NFATz and NFATx genes are in the same region.


Asunto(s)
Proteínas de Unión al ADN/química , Proteínas de Unión al ADN/genética , Proteínas Nucleares , Proteínas Proto-Oncogénicas c-rel/química , Factores de Transcripción/química , Factores de Transcripción/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Calcio/farmacología , Línea Celular , Núcleo Celular/química , Núcleo Celular/efectos de los fármacos , Núcleo Celular/metabolismo , Cromosomas Humanos Par 16/genética , Clonación Molecular , ADN/genética , ADN/metabolismo , Proteínas de Unión al ADN/metabolismo , Perfilación de la Expresión Génica , Humanos , Ratones , Datos de Secuencia Molecular , Factores de Transcripción NFATC , Filogenia , Mapeo Físico de Cromosoma , Unión Proteica , Estructura Terciaria de Proteína , ARN Mensajero/análisis , ARN Mensajero/genética , Elementos de Respuesta/genética , Homología de Secuencia de Aminoácido , Factor de Transcripción AP-1/metabolismo , Factores de Transcripción/metabolismo , Activación Transcripcional/genética
15.
Hinyokika Kiyo ; 45(2): 107-9, 1999 Feb.
Artículo en Japonés | MEDLINE | ID: mdl-10212783

RESUMEN

A 45-year-old man was referred to our department because of a right renal mass which was incidentally found at a health screening. Ultrasound sonography, computerized tomography and magnetic resonance imaging showed a hypovascular tumor 3 cm in diameter with the fluid at the upper pole of the right kidney, implicating that the tumor was renal cell carcinoma originating from a renal cyst wall, or with central necrosis. A radical nephrectomy was therefore performed. The tumor was dark-brown and contained brown fluid. The histopathological findings showed renal oncocytoma with cystic degeneration.


Asunto(s)
Adenoma Oxifílico/patología , Enfermedades Renales Quísticas/patología , Neoplasias Renales/patología , Adenoma Oxifílico/complicaciones , Carcinoma de Células Renales/patología , Diagnóstico Diferencial , Humanos , Enfermedades Renales Quísticas/complicaciones , Neoplasias Renales/complicaciones , Masculino , Persona de Mediana Edad
16.
Otolaryngol Head Neck Surg ; 120(2): 279-82, 1999 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9949367

RESUMEN

As a result of increasing use of bone marrow transplantation and new cytotoxic chemotherapy, more patients have become susceptible to sinus disease caused by unusual organisms. Sinusitis caused by fungi and gram-negative bacteria can be difficult to treat, may lead to severe complications, and should be managed promptly in the bone marrow transplant patient. Here we present the results of 41 cultures of the paranasal sinuses obtained from 18 bone marrow transplant patients in whom sinusitis developed. The most common agents were gram-negative bacteria (56.7%), followed by gram-positive bacteria (26.7%) and fungi (16.6%). In 13 samples the cultures were negative. Nasal cultures were performed ipsilateral to the sinus drained in 28 cases. Concordance was obtained in only 5 (17.8%) samples. The antibiogram of the isolated agents from the maxillary sinuses in this series revealed that the most efficient antibiotics were those that covered gram-negative bacteria. Treatment was usually prolonged in these patients, and different antibiotics were necessary to clear infections from the sinuses. In conclusion, treating sinusitis in bone marrow transplant patients may be challenging. Considerations about the microbiology and antibiogram susceptibilities of this specific population should be kept in mind when dealing with such cases.


Asunto(s)
Infecciones Bacterianas/microbiología , Trasplante de Médula Ósea , Seno Maxilar/microbiología , Sinusitis/microbiología , Antibacterianos/uso terapéutico , Infecciones Bacterianas/tratamiento farmacológico , Farmacorresistencia Microbiana , Quimioterapia Combinada , Femenino , Humanos , Masculino , Seno Maxilar/cirugía , Estudios Retrospectivos , Sinusitis/tratamiento farmacológico , Sinusitis/cirugía
17.
Hinyokika Kiyo ; 44(11): 801-3, 1998 Nov.
Artículo en Japonés | MEDLINE | ID: mdl-9893225

RESUMEN

A 70-year-old man, who was diagnosed by computed tomographic scan as having bilateral synchronous adrenal myelolipomas 6 years ago during the follow-up of fatty liver, underwent tumor resection at our Department because of growth of bilateral tumors without any subjective symptoms. Histopathological examination revealed mature adipose tissue cells without atypism and areas of hematopoietic tissue, including the myelotic, lymphotic, erythrocytic, and megakaryocytic cells. The diagnosis of myelolipoma was confirmed. The in vivo doubling time of bilateral tumors was 16.1 months and 31.3 months, respectively.


Asunto(s)
Neoplasias de las Glándulas Suprarrenales/patología , Mielolipoma/patología , Neoplasias Primarias Múltiples/patología , Neoplasias de las Glándulas Suprarrenales/cirugía , Anciano , Humanos , Imagen por Resonancia Magnética , Masculino , Mielolipoma/cirugía , Neoplasias Primarias Múltiples/cirugía
18.
Hinyokika Kiyo ; 44(11): 843-5, 1998 Nov.
Artículo en Japonés | MEDLINE | ID: mdl-9893235

RESUMEN

A 68-year-old woman admitted to our hospital complaining of urinary incontinence and dysuria. On examination, the labia were found to be fused extensively, with a pinhole opening at the midline. Under spinal anesthesia, the adhesion was clearly separated with the Hegar's dilator. There remains no recurrence in this patient following therapy. The labial adhesion was considered to be an acquired disease caused by infection, trauma in the genitalia, or sexless life, according to hypoestrogenism.


Asunto(s)
Posmenopausia , Incontinencia Urinaria/etiología , Trastornos Urinarios/etiología , Enfermedades de la Vulva/complicaciones , Anciano , Femenino , Humanos , Adherencias Tisulares/complicaciones
19.
Mol Cell Biol ; 17(4): 2066-75, 1997 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9121455

RESUMEN

The nuclear factor of activated T cells (NFAT) regulates cytokine gene expression in T cells through cis-acting elements located in the promoters of several cytokine genes. NFATx1, which is preferentially expressed in the thymus and peripheral blood leukocytes, is one of four members of the NFAT family of transcription factors. We have performed domain analysis of NFATx1 by examining the effects of deletion mutations. We found that NFATx1 DNA binding activity and interaction with AP-1 polypeptides were dependent on its central Rel similarity region and that transcriptional activation was reduced by deletions of either its N-terminal domain or its C-terminal domain, suggesting the presence of intrinsic transcriptional activation motifs in both regions. We also identified a potent inhibitory sequence within its N-terminal domain. We show that the inactivation of the inhibition was dependent on the activity of calcineurin, a calcium-calmodulin-dependent phosphatase. We also show that calcineurin associated with the N-terminal domain of NFATx1 at multiple docking sites and caused a reduction of size, indicative of dephosphorylation, in NFATx1. We have mapped the inhibitory activity to less than 60 residues, containing motifs that are conserved in all NFAT proteins. Finally, we demonstrate that deletion in NFATx1 of the mapped 60 residues leads to its nuclear translocation independent of calcium signaling. Our results support the model proposing that the N-terminal domain confers calcium-signaling dependence on NFATx1 transactivation activity by regulating its intracellular localization through a protein module that associates with calcineurin and is a target of its phosphatase activity.


Asunto(s)
Proteínas de Unión a Calmodulina/metabolismo , Proteínas de Unión al ADN/metabolismo , Proteínas Nucleares , Fosfoproteínas Fosfatasas/metabolismo , Factores de Transcripción/metabolismo , Secuencia de Aminoácidos , Animales , Sitios de Unión/genética , Transporte Biológico Activo , Células COS , Calcineurina , Línea Celular , Núcleo Celular/metabolismo , Citocinas/genética , ADN/genética , ADN/metabolismo , Proteínas de Unión al ADN/química , Proteínas de Unión al ADN/genética , Regulación de la Expresión Génica , Humanos , Células Jurkat , Datos de Secuencia Molecular , Estructura Molecular , Factores de Transcripción NFATC , Mapeo Peptídico , Eliminación de Secuencia , Homología de Secuencia de Aminoácido , Linfocitos T/metabolismo , Factores de Transcripción/química , Factores de Transcripción/genética
20.
J Biol Chem ; 271(41): 25423-9, 1996 Oct 11.
Artículo en Inglés | MEDLINE | ID: mdl-8810311

RESUMEN

We have identified a gene, cpdA, located at 66.2 min of the chromosome of Escherichia coli that encodes cyclic 3',5'-adenosine monophosphate phosphodiesterase (cAMP phosphodiesterase, EC). The expression of beta-galactosidase, which is a product of the lacZ gene, was repressed in cells that harbored multiple copies of the plasmid carrying the cpdA gene. Northern blotting showed that the transcription of the lacZ gene was inhibited in these cells. Multiple copies of the cpdA gene decreased the intracellular concentration of cAMP, which is a positive regulator for transcription of the lacZ gene. We found that the purified CpdA protein repressed in vitro transcription from the lacP1 promoter by decreasing cAMP. In addition, we showed that the CpdA protein hydrolyzed cAMP to 5'-adenosine monophosphate and that its activity was activated by iron. Our results suggested that regulation of intracellular concentration of cAMP is dependent not only on synthesis of cAMP but also on hydrolysis of cAMP by cAMP phosphodiesterase.


Asunto(s)
3',5'-AMP Cíclico Fosfodiesterasas/genética , Cromosomas Bacterianos , Escherichia coli/enzimología , Escherichia coli/genética , 3',5'-AMP Cíclico Fosfodiesterasas/biosíntesis , 3',5'-AMP Cíclico Fosfodiesterasas/química , Secuencia de Aminoácidos , Secuencia de Bases , Mapeo Cromosómico , Secuencia Conservada , AMP Cíclico/metabolismo , Genes Bacterianos , Histidina , Cinética , Datos de Secuencia Molecular , Mutagénesis , Plásmidos , Proteínas Recombinantes de Fusión/biosíntesis , Mapeo Restrictivo , beta-Galactosidasa/biosíntesis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA